CD8A and neoplasm: CD4+ helper T cells and cytotoxic CD8+ T cells play an important role in tumor prevention by targeting antigenic tumor cells, and CD8+ T cells are associated with better clinical outcomes and response to immunotherapy in many cancers (38–40).